Canada’s federal government, under Prime Minister Mark Carney, has unveiled a bold plan to slash the timeline for approving major projects to just one year, addressing long-standing complaints from businesses that regulatory delays stifle investment. Announced on Friday by Intergovernmental Affairs Minister Dominic LeBlanc and Transport Minister Steven MacKinnon, the initiative aims to streamline a process that has often dragged

Toronto, Ontario–(Newsfile Corp. – May 8, 2026) – ONGold Resources Ltd. (TSXV: ONAU) (OTCQB: ONGRF) (the “Company” or “ONGold“) announces that Gregory Duras is no longer serving as Chief Financial Officer and Corporate Secretary of the Company, effective May 7, 2026. The Company has appointed Soo-Whan Kim, previously its Corporate Controller, as Chief Financial Officer and Corporate Secretary, effective May

Vancouver, British Columbia–(Newsfile Corp. – May 8, 2026) – Tajiri Resources Corp. (TSXV: TAJ) (the “Company” or “Tajiri“) announces that, further to its news release dated September 2, 2025, it has issued an aggregate of 40,000,000 common shares of the Company (the “Consideration Shares“) to the shareholders of Nebula Resources Inc. (“Nebula“), in accordance with the terms of the previously completed

By David Bautz, PhD NASDAQ: CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Planning for Phase 3 Registration Trial of CAD-1005 in HIT On April 30, 2026, Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) announced an ‘End-of-Phase 2’ meeting with the U.S. Food and Drug Administration (FDA) in which the agency provided critical guidance on the company’s upcoming Phase 3 pivotal